Home > Income Statement > CIPLA

CIPLA
Revenue

    Back to Income Statement
CIPLA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
AD     Remove this Ad

CIPLA Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹25,774 Cr₹22,753 Cr₹21,763 Cr₹19,160 Cr₹17,132 Cr

What is the latest Revenue of CIPLA ?

The latest Revenue ratio of CIPLA is ₹25,774 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹25,774 Cr
Mar2024₹22,753 Cr
Mar2023₹21,763 Cr
Mar2022₹19,160 Cr
Mar2021₹17,132 Cr

How is Revenue of CIPLA Trending?

Years Revenue % Change
Mar2025 ₹25,774 Cr
13.28
Mar2024 ₹22,753 Cr
4.55
Mar2023 ₹21,763 Cr
13.59
Mar2022 ₹19,160 Cr
11.84
Mar2021 ₹17,132 Cr -

Compare Revenue of peers of CIPLA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CIPLA ₹96,402.9 Cr -4.1% -11.5% -19% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,603.0 Cr -5.6% -2.5% -1.7% Stock Analytics
DIVIS LABORATORIES ₹155,485.0 Cr -2.6% -8.7% 1.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹135,009.0 Cr -7.2% -8% 27.6% Stock Analytics
DR REDDYS LABORATORIES ₹101,628.0 Cr -6.5% -5.4% 3.9% Stock Analytics
MANKIND PHARMA ₹82,460.4 Cr -1.1% -11.1% -16.9% Stock Analytics


CIPLA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
CIPLA

-4.1%

-11.5%

-19%

SENSEX

-1%

-10.9%

-6%


You may also like the below Video Courses